Jun 17 |
BioMarin to Present Data Highlighting Significant Impact of VOXZOGO® (vosoritide) in Bone Health and Health-Related Quality of Life in Achondroplasia at 2024 International Conference on Children's Bone Health
|
Jun 7 |
KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
|
Jun 7 |
BioMarin Presents New Phase 3, Four-Year Data Underscoring Long-Term Safety and Efficacy of ROCTAVIAN® (valoctocogene roxaparvovec-rvox) at International Society on Thrombosis and Haemostasis 2024 Congress
|
Jun 5 |
June’s Biotech Boom: 3 Stocks to Buy for a Summertime Surge
|
Jun 4 |
BridgeBio data show sustained benefit for achondroplasia drug
|
May 27 |
BioMarin Pharmaceutical (NASDAQ:BMRN) shareholders have endured a 15% loss from investing in the stock a year ago
|
May 24 |
BioMarin (BMRN) Down 7.6% Since Last Earnings Report: Can It Rebound?
|
May 19 |
Li Auto Was One Of The Worst-Performing Stocks Last Week: Are These 10 Large-Cap Stocks Losers In Your Portfolio? (May 12-May 18, 2024)
|
May 18 |
4 Incomparable Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
|
May 17 |
Walmart To Rally Over 17%? Here Are 10 Top Analyst Forecasts For Friday
|